179 related articles for article (PubMed ID: 16863453)
1. Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates.
Sahi J
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):409-27. PubMed ID: 16863453
[TBL] [Abstract][Full Text] [Related]
2. Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity.
Feng B; El-Kattan AF; Radi ZA
Curr Protoc Toxicol; 2012 Aug; Chapter 23():Unit 23.3.1-15. PubMed ID: 22896010
[TBL] [Abstract][Full Text] [Related]
3. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.
Chu X; Chan GH; Evers R
J Pharm Sci; 2017 Sep; 106(9):2357-2367. PubMed ID: 28416420
[TBL] [Abstract][Full Text] [Related]
4. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
Kusuhara H; Sugiyama Y
Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
[TBL] [Abstract][Full Text] [Related]
5. Transporters and renal drug elimination.
Lee W; Kim RB
Annu Rev Pharmacol Toxicol; 2004; 44():137-66. PubMed ID: 14744242
[TBL] [Abstract][Full Text] [Related]
6. Transporters and xenobiotic disposition.
Kim RB
Toxicology; 2002 Dec; 181-182():291-7. PubMed ID: 12505328
[TBL] [Abstract][Full Text] [Related]
7. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
Feng B; LaPerle JL; Chang G; Varma MV
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
[TBL] [Abstract][Full Text] [Related]
8. Renal drug-drug interactions: what we have learned and where we are going.
Lepist EI; Ray AS
Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):433-48. PubMed ID: 22372422
[TBL] [Abstract][Full Text] [Related]
9. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
Mao Q; Lai Y; Wang J
Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
[TBL] [Abstract][Full Text] [Related]
10. [Drug membrane transporters in the liver: regulation of their expression and activity].
Fardel O; Payen L; Sparfel L; Vernhet L; Lecureur V
Ann Pharm Fr; 2002 Nov; 60(6):380-5. PubMed ID: 12514503
[TBL] [Abstract][Full Text] [Related]
11. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
Yang X; Han L
Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
[TBL] [Abstract][Full Text] [Related]
12. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.
Knights KM; Miners JO
Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654
[TBL] [Abstract][Full Text] [Related]
13. Organic anion transporters.
Tsuji A; Tamai I
Pharm Biotechnol; 1999; 12():471-91. PubMed ID: 10742985
[No Abstract] [Full Text] [Related]
14. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).
Varma MV; Steyn SJ; Allerton C; El-Kattan AF
Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985
[TBL] [Abstract][Full Text] [Related]
15. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps.
Okudaira N
J Pharm Sci; 2017 Sep; 106(9):2251-2256. PubMed ID: 28533120
[TBL] [Abstract][Full Text] [Related]
17. Renal transporters in drug development.
Morrissey KM; Stocker SL; Wittwer MB; Xu L; Giacomini KM
Annu Rev Pharmacol Toxicol; 2013; 53():503-29. PubMed ID: 23140242
[TBL] [Abstract][Full Text] [Related]
18. Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery research.
Tang H; Shen DR; Han YH; Kong Y; Balimane P; Marino A; Gao M; Wu S; Xie D; Soars MG; O'Connell JC; Rodrigues AD; Zhang L; Cvijic ME
J Biomol Screen; 2013 Oct; 18(9):1072-83. PubMed ID: 24062352
[TBL] [Abstract][Full Text] [Related]
19. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.
Scotcher D; Jones C; Posada M; Galetin A; Rostami-Hodjegan A
AAPS J; 2016 Sep; 18(5):1082-1094. PubMed ID: 27506526
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
Kusuhara H; Sugiyama Y
Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
